Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.

Alpha-2 Heremans Schmid Glycoprotein (AHSG) modulates signaling pathways in head and neck squamous cell carcinoma cell line SQ20B.

Thompson PD, Sakwe A, Koumangoye R, Yarbrough WG, Ochieng J, Marshall DR.

Exp Cell Res. 2014 Feb 15;321(2):123-32. doi: 10.1016/j.yexcr.2013.12.003. Epub 2013 Dec 12.

2.

Tumor suppressive microRNA-218 inhibits cancer cell migration and invasion through targeting laminin-332 in head and neck squamous cell carcinoma.

Kinoshita T, Hanazawa T, Nohata N, Kikkawa N, Enokida H, Yoshino H, Yamasaki T, Hidaka H, Nakagawa M, Okamoto Y, Seki N.

Oncotarget. 2012 Nov;3(11):1386-400.

3.

Loss of expression and function of SOCS3 is an early event in HNSCC: altered subcellular localization as a possible mechanism involved in proliferation, migration and invasion.

Rossa C Jr, Sommer G, Spolidorio LC, Rosenzweig SA, Watson DK, Kirkwood KL.

PLoS One. 2012;7(9):e45197. doi: 10.1371/journal.pone.0045197. Epub 2012 Sep 18.

4.

Tumour-suppressive microRNA-29s inhibit cancer cell migration and invasion by targeting laminin-integrin signalling in head and neck squamous cell carcinoma.

Kinoshita T, Nohata N, Hanazawa T, Kikkawa N, Yamamoto N, Yoshino H, Itesako T, Enokida H, Nakagawa M, Okamoto Y, Seki N.

Br J Cancer. 2013 Nov 12;109(10):2636-45. doi: 10.1038/bjc.2013.607. Epub 2013 Oct 3.

5.

Silencing heat shock protein 27 decreases metastatic behavior of human head and neck squamous cell cancer cells in vitro.

Zhu Z, Xu X, Yu Y, Graham M, Prince ME, Carey TE, Sun D.

Mol Pharm. 2010 Aug 2;7(4):1283-90. doi: 10.1021/mp100073s.

6.

Identification of a novel therapeutic target for head and neck squamous cell carcinomas: a role for the neurotensin-neurotensin receptor 1 oncogenic signaling pathway.

Shimizu S, Tsukada J, Sugimoto T, Kikkawa N, Sasaki K, Chazono H, Hanazawa T, Okamoto Y, Seki N.

Int J Cancer. 2008 Oct 15;123(8):1816-23. doi: 10.1002/ijc.23710.

7.

MMP-10/stromelysin-2 promotes invasion of head and neck cancer.

Deraz EM, Kudo Y, Yoshida M, Obayashi M, Tsunematsu T, Tani H, Siriwardena SB, Keikhaee MR, Qi G, Iizuka S, Ogawa I, Campisi G, Lo Muzio L, Abiko Y, Kikuchi A, Takata T.

PLoS One. 2011;6(10):e25438. doi: 10.1371/journal.pone.0025438. Epub 2011 Oct 5. Erratum in: PLoS One. 2012;7(2). doi: 10.1371/annotation/ef18e199-e66d-43b9-97e0-96d1ab149193. Kiekhaee, Mohammad Reza [corrected to Keikhaee, Mohammad Reza].

8.

Involvement of focal adhesion kinase in cellular invasion of head and neck squamous cell carcinomas via regulation of MMP-2 expression.

Canel M, Secades P, Garzón-Arango M, Allonca E, Suarez C, Serrels A, Frame M, Brunton V, Chiara MD.

Br J Cancer. 2008 Apr 8;98(7):1274-84. doi: 10.1038/sj.bjc.6604286. Epub 2008 Mar 18.

9.

Collagen type XI α1 facilitates head and neck squamous cell cancer growth and invasion.

Sok JC, Lee JA, Dasari S, Joyce S, Contrucci SC, Egloff AM, Trevelline BK, Joshi R, Kumari N, Grandis JR, Thomas SM.

Br J Cancer. 2013 Dec 10;109(12):3049-56. doi: 10.1038/bjc.2013.624. Epub 2013 Nov 14.

10.

RhoC mediates epidermal growth factor-stimulated migration and invasion in head and neck squamous cell carcinoma.

Tumur Z, Katebzadeh S, Guerra C, Bhushan L, Alkam T, Henson BS.

Neoplasia. 2015 Jan;17(1):141-51. doi: 10.1016/j.neo.2014.12.002.

11.

Expression of Oct3/4 and Nanog in the head and neck squamous carcinoma cells and its clinical implications for delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma.

Habu N, Imanishi Y, Kameyama K, Shimoda M, Tokumaru Y, Sakamoto K, Fujii R, Shigetomi S, Otsuka K, Sato Y, Watanabe Y, Ozawa H, Tomita T, Fujii M, Ogawa K.

BMC Cancer. 2015 Oct 19;15:730. doi: 10.1186/s12885-015-1732-9.

12.

Expression of CXCR4 and its down-regulation by IFN-gamma in head and neck squamous cell carcinoma.

Katayama A, Ogino T, Bandoh N, Nonaka S, Harabuchi Y.

Clin Cancer Res. 2005 Apr 15;11(8):2937-46.

13.

Fibroblasts and extracellular matrix differently modulate MMP activation by primary and metastatic head and neck cancer cells.

Koontongkaew S, Amornphimoltham P, Monthanpisut P, Saensuk T, Leelakriangsak M.

Med Oncol. 2012 Jun;29(2):690-703. doi: 10.1007/s12032-011-9871-6. Epub 2011 Mar 6.

PMID:
21380786
14.
15.

JunB promotes cell invasion, migration and distant metastasis of head and neck squamous cell carcinoma.

Hyakusoku H, Sano D, Takahashi H, Hatano T, Isono Y, Shimada S, Ito Y, Myers JN, Oridate N.

J Exp Clin Cancer Res. 2016 Jan 12;35:6. doi: 10.1186/s13046-016-0284-4.

16.

TGF-beta1 induced MMP-9 expression in HNSCC cell lines via Smad/MLCK pathway.

Sinpitaksakul SN, Pimkhaokham A, Sanchavanakit N, Pavasant P.

Biochem Biophys Res Commun. 2008 Jul 11;371(4):713-8. doi: 10.1016/j.bbrc.2008.04.128. Epub 2008 May 5.

PMID:
18457660
17.

Knockdown of HPIP Inhibits the Proliferation and Invasion of Head-and-Neck Squamous Cell Carcinoma Cells by Regulating PI3K/Akt Signaling Pathway.

Chen Y, Zhao R, Zhao Q, Shao Y, Zhang S.

Oncol Res. 2016;24(3):153-60. doi: 10.3727/096504016X14612603423476.

PMID:
27458096
18.

Loss of TGF-β signaling and PTEN promotes head and neck squamous cell carcinoma through cellular senescence evasion and cancer-related inflammation.

Bian Y, Hall B, Sun ZJ, Molinolo A, Chen W, Gutkind JS, Waes CV, Kulkarni AB.

Oncogene. 2012 Jul 12;31(28):3322-32. doi: 10.1038/onc.2011.494. Epub 2011 Oct 31.

19.

Osteoactivin Promotes Migration of Oral Squamous Cell Carcinomas.

Arosarena OA, Dela Cadena RA, Denny MF, Bryant E, Barr EW, Thorpe R, Safadi FF.

J Cell Physiol. 2016 Aug;231(8):1761-70. doi: 10.1002/jcp.25279. Epub 2016 Feb 8.

PMID:
26636434
20.

Inhibition of head and neck squamous cell carcinoma growth and invasion by the calcium influx inhibitor carboxyamido-triazole.

Wu Y, Palad AJ, Wasilenko WJ, Blackmore PF, Pincus WA, Schechter GL, Spoonster JR, Kohn EC, Somers KD.

Clin Cancer Res. 1997 Nov;3(11):1915-21.

Supplemental Content

Support Center